Veredus Laboratories

Veredus Laboratories recently introduced VereMERS, a lab-on-a-chip application capable of detecting from a sequence perspective the coronavirus that causes Middle East Respiratory Syndrome.

Veredus Laboratories, a Singapore-based molecular diagnostics company, last week launched VereTrop, a biochip that the firm claims can identify 13 major tropical diseases from a single blood sample, including dengue fever, malaria, chikungunya disease and hand, f

Becton Dickinson said this week that it has received clearance from the US Food and Drug Administration to market the BD Max Cdiff assay.

Affymetrix last week launched its Axiom high-density genotyping arrays for genome-wide evaluation of microRNA target sites.

Based on the firm's PCR and microarray platform, VereFoodborne can detect between 10 and 12 food-borne pathogens simultaneously, including E. coli, Salmonella, Listeria, and Campylobacter.

Meridian Bioscience's Illumigene C. difficile test; Nanosphere's Verigene SP respiratory virus panel; Veredus Laboratories' VereFlu test and VereID Biosystem; and IMDx's 2009 influenza H1N1 assay

The firm next quarter will debut VereFoodborne, a new assay for use in food testing that also runs on its VereID platform, which is manufactured by ST Microelectronics. VereFoodborne is one in a pipeline of tests the company plans to introduce this year.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.